Kosuke Hashimoto

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

A Case of Tumor Embolism to the Lower Extremity Artery Caused by Pulmonary Sarcoma With Left Atrial Invasion.

A Case of Tumor Embolism to the Lower Extremity Artery Caused by Pulmonary Sarcoma With Left Atrial Invasion.

Journal: Clinical case reports

Published: May 18, 2026

Synchronous occurrence of interstitial lung disease and ICANS after tarlatamab initiation in recurrent small-cell lung cancer.

Synchronous occurrence of interstitial lung disease and ICANS after tarlatamab initiation in recurrent small-cell lung cancer.

Journal: Respiratory medicine case reports

Published: January 24, 2026

Real-world occurrence of severe gastrointestinal bleeding in patients receiving amivantamab plus lazertinib: A two-case series among 25 consecutive cases.

Real-world occurrence of severe gastrointestinal bleeding in patients receiving amivantamab plus lazertinib: A two-case series among 25 consecutive cases.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 19, 2026

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.

Journal: Current oncology (Toronto, Ont.)

Published: January 07, 2026

TROP2 expression as a prognostic predictor for osimertinib in patients with EGFR-mutant non-small cell lung cancer.

TROP2 expression as a prognostic predictor for osimertinib in patients with EGFR-mutant non-small cell lung cancer.

Journal: Translational lung cancer research

Published: December 28, 2025

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study.

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study.

Journal: Scientific reports

Published: November 05, 2025

G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report.

G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report.

Journal: Respiratory medicine case reports

Published: October 20, 2025

Prognostic value as metabolic tumor activity on 18F-FDG uptake in thymic epithelial tumors.

Prognostic value as metabolic tumor activity on 18F-FDG uptake in thymic epithelial tumors.

Journal: Journal of thoracic disease

Published: October 17, 2025

Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer.

Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: August 29, 2025

Metabolic tumor volume on 18F-fluorodeoxyglucose uptake as prognostic marker for osimertinib in patients with non-small cell lung cancer harboring sensitive EGFR mutation.

Metabolic tumor volume on 18F-fluorodeoxyglucose uptake as prognostic marker for osimertinib in patients with non-small cell lung cancer harboring sensitive EGFR mutation.

Journal: Translational lung cancer research

Published: July 06, 2025

A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling.

A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling.

Journal: In vivo (Athens, Greece)

Published: June 23, 2025

The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment.

The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment.

Journal: Nature communications

Published: May 30, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026